Catalyst Crew Technologies Corp. has appointed Dr. Kevin Rodan Levy as Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer, and Sole Director, effective February 17, 2026. The leadership transition follows the resignation of the company's prior officers and directors, as disclosed in a Form 8-K filed with the U.S. Securities and Exchange Commission.
Dr. Rodan brings a combination of clinical medical training, healthcare operations experience, and technology platform leadership to his new role. Since 2021, he has served as CEO of Grupo Casamed 18 C.A., where he focused on healthcare delivery management and organizational development. He has also led EmpleUp, a technology-focused human capital and recruitment platform. This background aligns with Catalyst Crew's strategic transition toward artificial intelligence-enabled healthcare technology solutions.
The appointment signals the company's commitment to advancing its recently announced strategic direction. Catalyst Crew Technologies is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with initial emphasis on Latin America. The company is pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination.
"I am honored to lead Catalyst Crew Technologies Corp. at this pivotal stage in its evolution," said Dr. Rodan. "Our focus is on disciplined execution of the Company's strategic transition into AI-enabled healthcare solutions, with particular emphasis on scalable platforms that address access and efficiency challenges in emerging markets. We are committed to building a strong operational foundation and advancing initiatives that position the Company for long-term sustainable development."
This leadership change matters because it represents a significant step in the company's transformation from its previous business direction to a focused AI healthcare strategy. For investors and industry observers, the appointment of an executive with both healthcare operations and technology experience suggests serious intent to execute on the announced strategic shift. The company's focus on emerging markets, particularly Latin America, addresses a growing need for modernized healthcare delivery systems in regions where traditional infrastructure may be limited.
The company intends to continue providing updates through filings with the U.S. Securities and Exchange Commission and other public disclosures as appropriate. For more details about the company, visit https://catalystcrewai.com, or access its official filings through the U.S. Securities and Exchange Commission website at https://www.sec.gov.
Catalyst Crew Technologies is a development-stage enterprise that has not generated revenues from its newly announced business direction. The company's forward-looking statements regarding business strategy, leadership initiatives, strategic transactions, and operational execution involve risks and uncertainties. Actual results may differ materially due to various factors including the company's ability to successfully implement its business plan, secure financing, complete acquisitions, comply with regulatory requirements, and navigate general market and economic conditions.
